• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Curriculum Vitae

Curriculum Vitae






Total Views
Views on SlideShare
Embed Views



0 Embeds 0

No embeds


Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
Post Comment
Edit your comment

    Curriculum Vitae Curriculum Vitae Document Transcript

    • Curriculum Vitae October 19, 2010 Name: Nancy Elsa Mueller (formerly Gutensohn) Date of Birth: August 26, 1938 Education Degree Discipline Institution Date BA (cum laude) Biology Beloit College 1961 SM Epidemiology Harvard School of Public Health 1974 SD Epidemiology Harvard School of Public Health 1980 Research and Professional Experience University of Wisconsin Medical School Research Assistant, Department of Clinical Oncology 1961-1963 Research Assistant, McArdle Laboratory for Cancer Research 1966-1968 Harvard School of Public Health Teaching Fellow in Epidemiology 1975-1980 Assistant Professor of Epidemiology 1980-1984 Associate Professor of Epidemiology 1985-1991 Professor of Epidemiology 1991-2008 Professor of Epidemiology Emerita 2009- Massachusetts Cancer Registry Research Subcommittee, 1984-1994 Chair 1986-1987 Advisory Committee, Chair 1995-2006 AIDS Institute Research Council, State of New York 1984-1986 AIDS Research Council, Commonwealth of Massachusetts 1984-1986
    • Graduate Summer Session in Epidemiology Faculty University of Minnesota 1985 University of Michigan 1991, 1993-1999 Cancer Control Research Unit for Connecticut at Yale: Scientific Advisory Committee 1986-1991 Harvard University Extension School, Faculty 1986-1988 Harvard University Study Group on AIDS & Public Policy 1986-1989 PHS Task Force on Public Health Curriculum on AIDS 1987 National Review Panel, AIDS Education Project for Minority Youth; National Coalition of Advocates for Students 1987-1994 Advisory Committee, Newborn Seroprevalence Survey, NIH 1987-1988 American Foundation for AIDS Research, Scientific Advisory Committee, Ad hoc Member 1987-1989 Member 1990-1992 "Epidemiology and natural history of AIDS" Panel Chair, Society for Epidemiologic Research Annual Meeting, 1987 National Advisory Council, AIDS Subcommittee Ad hoc Member, NIAID 1988-1990 Symposium, “The Epidemiology of HIV infection: Transmission and Natural History” AAAS Annual Meeting (Convener) 1988 Division of AIDS Research Advisory Committee & AIDS Liaison 1990-1993 Subcommittee, NIAID International Panel of Scientific Advisors, National 1989-1991 Cancer Institute, Fondazione Pascale, Naples, Italy Editorial Board, Epidemiology 1990-1993 Myeloma Working Group, Divisions of Cancer Biology Diagnosis and Cancer Etiology, NCI 1989-1990 American College of Epidemiology, Fellow 1990- External Review Committee, Epidemiology and Biostatistics Program, 2
    • University of Miami Sylvester Comprehensive Cancer Center 1990 Fourth International Conference on Human Retrovirology: HTLV Program Committee; Chair, Epidemiology 1990 Eighth International Conference on AIDS Program Committee: Epidemiology Track 1990-1992 Ad hoc Review: "Women and Infants Transmission Study", NIAID (DAIDS) 1990 Ad hoc Review: "Heterosexual AIDS Transmission Study", NIAID (DAIDS) (Chair) 1990 American Epidemiology Society, Member 1991- Ad hoc IARC Monographs Advisory Group on Viruses and other Biologic Agents such as Parasites, Rapporteur 1991 Harvard/Bundesgesundheitsamt Epidemiology Course Faculty, Berlin 1991 External Program Review Committee, Retrovirus Diseases Branch, Division of Viral and Rickettsial Disease, CDC 1991 American Journal of Epidemiology Associate Editor 1992 -1997 Review Committee, Environmental Epidemiology Program, 1992 Veteran's Administration (Chair) Expert Panel: Review of Long Island Breast Cancer Incidence, 1992 Division of Cancer Prevention and Control, CDC Program Review: National Cooperation Vaccine Development Groups, NIAID (DAIDS) 1992 International Retrovirology Association: HTLV and Related Viruses: Planning Committee 1992 Charter Member 1993 Advisory Board 1994-1997 IARC Monographs Working Group: Hepatitis Viruses 1993 American Association for Cancer Research 1993-2008 Board of Scientific Counselors, Division of Cancer Etiology, NCI 1993-1995 International Association for Research on EBV and Associated Diseases 1993-2006 3
    • Harvard Center for Cancer Prevention, Executive Committee 1993-2006 Editorial Committee, Revista del Instituto Nacional de Cancerologia "Mexico" 1994-2006 Sixth International Conference on Human Retrovirology: HTLV Conference Scientific Committee 1994 Project Review: "EMF, OCPs and breast cancer on Long Island, N.Y.," SUNY at Stony Brook, NCI (Chair) 1994 Program Review: "Viral Epidemiology Branch of Division of Cancer Etiology", NCI (Chair) 1995 Project Review: "Women's Interagency HIV Study", NIAID (Chair) 1996 IARC Monographs Working Group: HIV and HTLV 1996 Board of Scientific Advisors, NCI 1996-2004 Board of the Medical Follow-up Agency, Institute of Medicine 1996-2003 Review Panel of studies of transplacental toxicity of AZT, NIAID 1997 IARC Monographs Working Group: Gamma Herpesviruses: Epstein-Barr Virus and Human Herpesvirus 8 (Chair) 1997 Science Research Review Committee, American Cancer Society Massachusetts Division 1997-2002 Editorial Board, Journal of Human Virology 1997-2000 5 A Day for Better Health Foundation Advisory Meeting, NCI 1997 Advisory Committee, Cooperative Family Registry for 1997-2001 Breast Cancer Studies, NCI SPORE Grant Evaluation Subcommittee, NCI 1998 Surveillance Implementation Group, NCI 1998 Ad hoc Tenure Review Committee, Columbia University 1998 IARC International Course: “Infections that increase the risk of cancer” Faculty member 1998; 2001 Ninth International Conference on Human Retrovirology: Organizing Committee; Workshop co-Leader 1999 4
    • Program Review: Viral Epidemiology Branch, NCI 1999 Society of Epidemiological Research Annual Meeting: Tutorial leader: “Infections and Cancer” 1999 Dana Farber/Harvard Cancer Center: Associate Director for Population Sciences 1999- 2007 Director: Rapid Case Identification Core 1999- 2008 Advisory Workshop: Epidemiology and Genetics Research Program NCI, (Chair) 1999 NIH Molecular Biology & Pathogenesis of HTLV-I Workshop (Discussant) 2000 Society of Epidemiological Research Annual Meeting: Symposium Chair: “Infections and Cancer: Establishing Cause And Causal Mechanisms” 2000 Workshop on Hodgkin’s Disease, International Association for Research on EBV and Associated Diseases Annual Meeting, co-leader 2000 National Cancer Policy Board 2000-2003 External Advisory Board, Kaplan Comprehensive Cancer Center New York University 2001-2008 NCI Leukemia, Lymphoma, and Myeloma Progress Review Group Roundtable (Participant) 2001 External Advisory Board, Sylvester Cancer Center University of Miami 2001-2007 NCI Working Group: Biological Carcinogenesis Research Network 2002 NCI Workshop: “Gene-Environment Interactions in the Etiology of Childhood Cancer” Panel Co-Chair 2002 Epidemiology and Genetics Research Program Planning Group, NCI (Chair) 2002 International Consortium of Investigators Working on Epidemiologic Studies of Lymphoma (InterLymph) Immunology sub-group 2002-2006 ACS Award for Research Excellence in Cancer Epidemiology and Prevention Committee, AACR 2003 Eleventh International Conference on Human Retrovirology: Organizing Committee; Workshop co-Leader 2003 Women and Cancer Research Update 2003, Harvard Medical School’s Center 5
    • Excellence in Women’s Heath: Panel Moderator 2003 Lymphoma Research Foundation: Environmental Working Group 2003-4 External Advisory Board, Johns Hopkins University Lymphoma SPORE 2004-2006 Advisory Board, DF/HCC Ovarian SPORE 2004-2007 Harvard Women’s Leadership Project, panel member 2004 NCI Committee, Establishing Criteria for Validating Assays: SV40 2004 NCI Division of Cancer Epidemiology & Genetics, Visiting Scholar 2005 IARC Monographs Working Group: Biological Agents (co-Chair) 2009 Awards American Cancer Society Faculty Research Award 1988-1992 MERIT Award, National Cancer Institute: "Natural history 1988-1993 of HTLV-I infection" NCI 5 R37 CA38450 Citation for Excellence in Teaching, HSPH 1993 National Associate, National Academies 2003 6
    • Original Publications 1. Gutensohn, N., Li, F.P., Johnson, R.E., Cole, P., Hodgkin's disease, tonsillectomy and family size. N Engl J Med 292: 22-25, 1975. 2. Gutensohn, N., Cole, P., Childhood social environment and Hodgkin's disease. N Engl J Med 304: 135-140, 1981. 3. Barnett, A.I., Rutherford, C.J., Desforges, J.F., Gutensohn, N., Davies, B., Evaluating the validity of a Bayesian program for predicting stage in Hodgkin's disease. Meth Inform Med 20: 174-178, 1981. 4. Gutensohn, N., Shapiro, D.S., Social class factors among children with Hodgkin's disease. Int J Cancer 30: 433-435, 1982. 5. Gallo, R.C., Kalyanaraman, V.S., Sarngadharan, M.G., Sliski, A., Vonderheid, E.C., Maeda, M., Nakao, Y., Yamada, K., Ito, Y., Gutensohn, N., et al., Association of the Human type C Retrovirus with a subset of adult T-cell cancers. Cancer Research 43: 3892-3899, 1983. 6. Scherr, P.A., Gutensohn, N., Cole, P., School contact among persons with Hodgkin's disease. Amer J Epi 120: 29-38, 1984. 7. Evans, A.S., Gutensohn, N.M., A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer 34: 149-158, 1984. 8. Mueller, N.E., Hsieh, C.-c., Swanson, M., Cole, P., Tonsillectomy and Hodgkin's disease: Results from companion population-based studies. JNCI 78: 1-5, 1987. 9. Mueller, N., Hinkula, J., Wahren, B., Elevated antibody titers against cytomegalovirus among patients with testicular cancer. Int J Cancer 41: 399-403, 1988. 10. Archibald, D., Essex, M., McLane, M.F., Sauk, J., Tachibana, N., Mueller, N., Antibodies to HTLV-I in saliva of seropositive individuals from Japan. Viral Immunology 1: 241-6, 1988. 11. Ishizaki, J., Okayama, A.,Tachibana, N., Yokota, T., Shishime, E., Tsuda, K., Mueller, N., Comparative diagnostic assay results for detecting antibody to HTLV-I in Japanese blood donor samples: Higher positive rates by the particle agglutination assay. JAIDS 1: 340-345, 1988. 12. Tachibana, N., Okayama, A., Ishizaki, J., Yokota, T., Shishime, E., Murai, K., Shioiri, S., Tsuda, K., Essex, M., Mueller, N., Suppression of tuberculin skin reaction in healthy HTLV-I carriers from Japan. Int J Cancer 42: 829-831, 1988. 13. Turner, S.B., Kunches, L.M., Gordon, K.F., Travers, P.H., Mueller, N.E., Occupational exposure to human immunodeficiency virus and hepatitis B virus in embalmers: A 7
    • seroprevalence study. Amer J Pub Health 79: 1425-6, 1989. 14. Mueller, N., Evans, A., Harris, N.L., Comstock, G.W., Jellum, E., Magnus, K., Orentreich, N., Polk, B.F., Vogelman, J., Hodgkin's disease and EBV: Altered antibody pattern before diagnosis. N Engl J Med 320: 696-701, 1989. 15. Yokota, T., Cho, M-J., Tachibana, N., McLane, M.F., Takatsuki, K., Lee, T-H., Mueller, N., Essex, M., The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison to healthy carriers in Japan. Int J Cancer 43:970-974, 1989. 16. Murai, K., Tachibana, N., Shioiri, S., Shishime, E., Okayama, A., Ishizaki, J., Tsuda, K., Mueller, N., Suppression of delayed-type hypersensitivity to PPD and PHA in elderly HTLV-I carriers. JAIDS 3:1006-1009, 1990. 17. Chen, Y.-M. A., Gomez-Lucia, E., Okayama, A., Tachibana, N., Lee, T.-H., Mueller, N., Essex, M., Antibody profile of early HTLV-I infection. Lancet 336: 1214-1216, 1990. 18. Chen, Y.-M. A., Okayama, A., Lee, T.-H., Tachibana, N., Mueller, N., Essex, M., Sexual transmission of HTLV-I associated with the presence of the anti-tax antibody. Proc Natl Acad Sci USA 88:1182-1186, 1991. 19. Izazola-Licea, J.A., Valdespino-Gomez, J.L., Gortmaker, S.L., Townsend, J., Becker, J., Palacios-Martinez, M., Mueller, N.E., Sepulveda-Amor, J., HIV-I seropositivity and behavioral and sociological risks among homosexual and bisexual males in six Mexican cities. JAIDS 4:614-622, 1991. 20. Chan, C.K., Mueller, N., Evans, A., Harris, N.L., Comstock, G.W., Jellum, E., Magnus, K., Orentreich, N., Polk, B.F., Vogelman, J., Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma. Cancer Causes and Control 2:125-131, 1991. 21. Mueller, N., Mohar, A., Evans, A., Harris, N.L. Comstock, G.W., Jellum, E., Magnus, K., Orentreich, N., Polk, B.F., Vogelman, J., Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 49:387-393, 1991. 22. Okayama, A., Korber, B., Chen, Y.A., Allan, J, Lee, T.-H., Shioiri, S., Tachibana, N., Tsuda, K., Mueller, N., McLane, M.F., Maayan, S., Marlink, R., Orgad, S., Essex, M.,Unusual pattern of antibodies to HTLV-I in family members of adult T-cell leukemia patients. Blood 78:3323-3329, 1991. 23. Takahashi, K., Takezaki, T., Oki, T., Kawakami, K., Yashiki, S., Fujiyoshi, T., Usuku, K., Mueller, N. et al., Inhibitory effect of maternal antibody on mother-to-child transmission of human T-lymphotropic virus type I. Int J Cancer 49:673-677, 1991. 24. Stuver, S.O., Tachibana, N., Okayama, A., Romano, F., Yokota, T., Mueller, N., Determinants of HTLV-I seroprevalence in Miyazaki Prefecture Japan: A cross-sectional study. JAIDS 5:12-18, 1992. 8
    • 25. Mohar, A., De Gruttola, V., Mueller, N., Sepulveda, J., A model for the AIDS epidemic in Mexico: Short term projections. JAIDS 5:265-270, 1992. 26. Hernandez, M., Uribe P., Gortmaker, S., Avila, C., DeCaso E., Mueller, N., Sepulveda, J., Sexual behavior and status for human immunodeficiency virus type 1 among homosexual and bisexual males in Mexico City. Am J Epidemiol 135:883-894, 1992. 27. Mohar, A., Romo, J., Salido, F., Jessurun, J., Ponce de Leon, S., Reyes, E., Volkow, P., Larraza, O., Peredo, M.-A., Cano, C., Gomez, G., Sepulveda, J., Mueller, N., The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS 6:467-473, 1992. 28. Stuver, S.O., Tachibana N., Mueller, N., A case-control study of factors associated with HTLV-I infection in southern Miyazaki; Japan. J Natl Cancer Inst. 84:867-872, 1992. 29. Ishihara, S., Tachibana, N., Okayama, A., Murai, K. Tsuda, K., Mueller, N., Successful graft of HTLV-I transformed human T-cells (MT-2) in severe combined immunodeficiency mice treated with anti-asialo GM-1 antibody. Jap J Cancer Res 83:320-323, 1992. 30. Evans, A., Lefkopoulou, M., Mueller, N., Methods for inference on transmission in seroprevalence data for multiple infections. Amer J Epidem 135:1156-1165, 1992. 31. Tachibana, N., Okayama, A., Ishihara, S., Shioiri, S., Murai, K., Tsuda, K., Goya, N., Matsuo, Y., Essex, M., Stuver, S., Mueller, N., High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. Int J Cancer 51:593-595, 1992. 32. Stuver, S.O., Tachibana, N., Okayama, A., Shioiri, S., Tsunetoshi, Y., Tsuda, K., Mueller, N.E., Heterosexual transmission of human T-cell leukemia/lymphoma virus type I among married couples in South-western Japan: An initial report from the Miyazaki Cohort Study. J Infect Dis 167:57-65, 1993. 33. Shioiri, S., Tachibana, N., Okayama, A., Ishihara, S., Tsuda, K., Stuver, S., Mueller, N., Essex, M., Analysis of anti-tax antibody of HTLV-I carriers in an endemic area in Japan. Int J Cancer 53:1-4, 1993. 34. Welles, S.L., Tachibana, N., Okayama, A., Murai, K., Shioiri, S., Sagawa, K., Katagira, K., Mueller, N., The distribution of T-cell subsets among HTLV-I carriers in Japan. JAIDS 7:509-516, 1994. 35. Welles, S.L., Tachibana, N., Orav, J.E., Okayama, A., Ishizaki, J., Mueller, N.E., Change in hematologic parameters among Japanese HTLV-I carriers. JAIDS 7:92-7, 1994. 36. Ishihara, S., Okayama, A., Stuver, S., Horinouchi, A., Murai, K., Shioiri, S., Kubota, T., Yamashita, R., Tachibana, N., Mueller, N., Association of HTLV-I antibody profile of 9
    • asymptomatic carriers with proviral DNA levels of peripheral blood mononuclear cells. JAIDS 7:199-203,1994. 37. Welles, S.L., Tachibana, N., Okayama, A., Shioiri, S., Ishihara, S., Murai, K., Mueller, N.E., Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status. Int J Cancer 56:337-340, 1994. 38. Katsouyanni, K., Trichopoulou, A., Stuver, S., Stamatis, V., Papadiamantis, Y., Bournas, N., Skarpou N., Mueller, M., Trichopoulos, D., Ethanol and breast cancer: An association that may be both confounded and causal. Int J Cancer 58:356-61, 1994 39. Levine, P.H., Pallesen, G., Ebbesen, P., Harris, N., Evans, A.S., and Mueller, N., An evaluation of Epstein-Barr virus antibody patterns and the detection of viral markers in the biopsies of patients with Hodgkin's disease. Int J Cancer 59:48-50, 1994. 40. Okayama, A., Maruyama, T., Tachibana, N., Hayashi, T., Mueller, N., Tsubouchi, H., Increased prevalence of HTLV-I infection in patients with hepatocellular carcinoma associated with hepatitis C virus. Jap J Cancer Res 86:1-4, 1995. 41. Hadziyannis, S., Tabor, E., Kaklamani, E., Tzonou, A., Stuver, S., Tassopoulos, N., Mueller, N., Trichopoulos, D., A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 60:627-631, 1995. 42. Stuver, O., Tachibana, N., Okayama, A., Mueller, N.E., Evaluation of morbidity among HTLV-I carriers in Miyazaki, Japan. J Infect Dis 173:584-91, 1996. 43. Ishihara, S., Okayama, A., Nagatomo, Y., Murai, K., Yamashita, R., Okamoto, M., Shima, T., Sasaki, T., Mueller, N., Tachibana, N., Tsubouchi, H., Enhanced engraftment of HTLV-I infected human T-cells in severe combined immunodeficiency mice by anti-asialo GM-1 antibody treatment. Microbiology and Immunology 40:39-44, 1996. 44. Buonaguro, F.M., Tornesello, M.L., Beth-Giraldo, E., Hatzaki, A., Mueller, N., Downing, R., Biryamwaho, B., Sempala, S.D., Giraldo, G., Herpesvirus-like DNA sequences detected in endemic classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 65:25-28, 1996. 45. Stuver, S.O., Okayama, A., Tachibana, N., Tsubouchi, H., Mueller, N.E., Tabor, E., HCV infection and liver cancer mortality in a Japanese population with HTLV-I. Int J Cancer 67:35-37, 1996. 46. Coplan, P.M., Gortmaker, S.L., Hernandez, M., Spiegelman, D., Uribe, P., Mueller, N.E., HIV infection in Mexico City: Rectal bleeding and anal warts as risk factors among men having sex with men. Am J Epidemiol 144:817-827, 1996. 47. Shevitz, A., Pagano, M., Mueller, N., Chiasson, M.A., Thomas, P., The association between youth, women, and the acquired immunodeficiency syndrome. JAIDS 3:427-433, 1996. 48. Touloumi, G., Kaklamanis, L., Potouridou, I., Katsika-Hatziolou, E., Stratigos, J., Mueller, 10
    • N., Hatzakis, A., The epidemiologic profile of Kaposi's sarcoma in Greece prior and during the AIDS era. Int J Cancer 70:538-41, 1997. 49. Okayama, A., Tachibana, N., Ishihara, S., Nagatomo, Y., Murai, K., Kubota, T., Sagawa, K., Tsubouchi, H., Stuver, S., Mueller, N., Increased expression of interleukin 2 receptor . on peripheral blood mononuclear cells in HTLV-I tax/rex mRNA-positive asymptomatic carriers. JAIDS 15:70-75, 1997. 50. Tanaka, K., Stuver, S.O., Ikematsu, H., Okayama, A., Tachibana, N., Hirohata, T., Kashiwago, S., Tsubouchi, H., Mueller, N.E. Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan. Int J Cancer 72:50-55, 1997. 51. Etoh, K.-i., Tamiya, S., Yamaguchi, K., Okayama, A., Tsubouchi, H., Ideta, T., Mueller, N.,Takasuki, K., Matsuoka, M., Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res 57:4862-4867, 1997. 52. Shioiri, S., Stuver, S.O., Okayama, A., Murai, K., Shima, T., Tachibana, N.,Tsubouchi, H., Essex, M., Mueller, N.E. Intrafamilial transmission of HTLV-I and its association with anti- tax antibody in an endemic population in Japan. Int J Cancer 75:15-18, 1997. 53. Hisada, M., Okayama, A., Tachibana, N., Stuver, S.O., Spiegelman, D.L., Tsubouchi, H., Mueller, N.E., Predictors of level of circulating abnormal lymphocytes among human T- lymphotropic virus type I carriers in Japan. Int J Cancer 77: 188-192, 1998. 54. Hisada, M., Okayama, A., Shioiri, S., Spiegelman, D.L., Stuver, S.O., Mueller, N.E. Risk factors for adult T-cell leukemia among carriers of human T- lymphotropic virus type I. Blood 92:3557-3561, 1998. 55. Hisada, M., Shima, T., Okayama, A., Mueller, N., Tsubouchi H., Stuver, S. Suppression of skin reactivity to purified protein derivative (PPD) by hepatitis C virus among human T- lymphotropic virus type I carriers in Japan. JAIDS 19:421-425, 1998. 56. Sleckman, B.G., Mauch, P.M., Ambinder, R.F., Mann, R., Pinkus, G.S., Kadin, M.E., Sherburne, B., Perez-Atayde, A., Harris, N.L., Thior, I., Mueller, N. Epstein-Barr virus and Hodgkin's disease: Correlation of risk factors and disease characteristics with molecular evidence of viral infection. Cancer Epi Bio & Prev 7:1117-1121, 1998. 57. Etoh, K-i., Yamaguchi, K., Tokudome, S., Watanabe, T., Okayama, A., Stuver, S., Mueller, N., Takasuki, K., Matsuoka, M. Rapid quantification of HTLV-I provirus load: Detection of monoclonal proliferation of HTLV-I infected cells among carriers. Int J Cancer 81:859-864,1999. 58. Bohlke, K., Harlow, B.L., Cramer, D.W., Spiegelman, D., Mueller, N.E., Evaluation of a population roster as a source of population controls: The Massachusetts Resident Lists. Amer J Epidemiol 150:354-358, 1999. 11
    • 59. Touloumi, G., Hatzakis, A., Potouridou, I., Milona, I., Strarigos, J., Katsambas, A., Giraldo, G., Beth-Giraldo, E., Biggar, R.J., Mueller, N., Trichopoulos, D., The role of immunosuppression and immune-activation in classic Kaposi's sarcoma. Int J Cancer 82: 817-821,1999. 60. Suzuki, M., Dezzutti, C.S., Okayama, A., Tachibana, N., Tsubouchi, H., Mueller, N., Lal, R.B., Modulation of T-cell responses to a recall antigen in human T-cell leukemia virus type 1-infected individuals. Clin Diagn Lab Immunol 6:713-7,1999. 61. Hisada, M., Stuver, S.O., Okayama, A., Mueller, N.E. Gender difference in the prevalence of PPD anergy among carriers of human T-lymphotropic virus type I. JAIDS 22:302-307, 1999. 62. Boschi-Pinto, C., Stuver, S., Okayama, A., Trichopoulos, D., Orav, E.J., Tsubouchi, H., Mueller, N. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T-cell lymphotropic virus type I in Miyazaki, Japan. J Infect Dis 181:35-41,2000. 63. Hisada M., Okayama A., Spiegelman D.L., Mueller N.E., Stuver S.O., Sex-specific mortality from adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Int J Cancer 91:497-499, 2001. 64. Okayama A., Stuver S., Iga M., Okamoto M., Mueller N., Matsuoka M., Yamaguchi K., Tachibana N., Tsubouchi H. Sequential change of viral markers in seroconverters with community acquired infection of human T-lymphotropic virus type 1. J Infect Dis 183:1031-1037, 2001. 65. Arduino J.M., Stuver, S.O., Spiegelman D., Okayama A., Tabor E., Yu M.-y.W., Kohara M., Tsubouchi H., Mueller N.E. Assessment of markers of hepatitis C virus infection in a Japanese adult population. J Infect Dis, 184:1229-1235, 2001. 66. Iga M., Okayama A., Stuver S., Matsuoka M., Mueller N., Aoki M., Mitsuya H., Tachibana N., Tsubouchi H. Genetic evidence of transmission of human T-cell lymphotropic virus type I between spouses. J Infect Dis, 185:691-695, 2002. 67. Okayama A., Stuver S.O., Tabor E., Tachibana N., Kohara M., Mueller N.E., Tsubouchi H. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepatitis 9:43-51, 2002. 68. Chang E.T., Zheng T., Weir E., Borowitz M., Mann R., Mueller N. Regular aspirin use and reduced risk of Hodgkin’s lymphoma in a population-based case-control study. JNCI 96:305-315, 2004. 69. Chang E.T., Zheng T., Lennette E.T., Weir E., Borowitz M., Mann R.B., Spiegelman D., Mueller N.E. Heterogeneity of risk factors and antibody profiles in Epstein-Barr virus genome-positive and genome-negative Hodgkin’s lymphoma. J Infect Dis 189:2271-2281, 12
    • 2004. 70. Okayama, A., Stuver, S., Matsuoka, M., Ishizaki, J., Tanaka, G.-i., Kubuki, Y., Mueller, N., Yamaguchi, K., Hsieh, C-C., Tachibana, N., Tsubouchi, H. Role of HTLV-I proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 110:621-625, 2004. 71. Volkow, P., Velasco, S.R., Mueller, N., Sierra-Madero, G., Castillo, J.R., Mohar, A. Transfusion-associated HIV infection in Mexico related to paid blood donors’ HIV epidemic. Int J STD AIDS 15:337-342, 2004. 72. Chang, E.T., Zheng, T., Weir, E., Borowitz, M., Mann, R., Spiegelman, D., Mueller, N. Childhood social environment and Hodgkin’s lymphoma in a population–based case-control study. Cancer Epi Biomarkers Prev 13:1361-1370, 2004. 73. Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., Mueller N.E. Effect of hepatitis C virus infection on the risk of non-Hodgkin’s lymphoma: Analysis of epidemiological studies. Cancer Sci 95:745-752, 2004. 74. Hisada M., Stuver, S.O., Okayama, A., Li, H.-C., Sawada, T., Hanchard, B., Mueller, N.E. A persistent paradox of HTLV-I natural history: Parallel analyses of Japanese and Jamaican carriers. J Infect Dis 190:1605-1609,2004. 75. Birmann B.M., Mueller N., Okayama A., Hsieh C.C., Tachibana N., Tsubouchi H., Lennette E.T., Harn D., Stuver S. Serologic assessment of type 1 and type 2 immunity in healthy Japanese adults. Cancer Epidemiol Biomarkers Prev 13:1385-1391, 2004. 76. Matsuo, K., Hamajima, N., Suzuki, R., Ogura, M., Kagami, Y., Taji, H., Mueller, N.E., Nakamura, S., Seto, M., Morishima, Y., Tajima, K. Folate and methionine-metabolizing enzyme gene polymorphisms change susceptibility with regard to malignant lymphoma. Am J Hematology 77:351-357, 2004. 77. Gao, G., Stuver, S.O., Okayama, A., Tsubouchi, H., Mueller, N.E., Tabor, E. The minimum number of clones necessary to sequence in order to obtain the maximum information about hepatitis C virus quasispecies: A comparison of cases with and without liver cancer. J Viral Hepatitis 12:46-50,2005. 78. Tanaka G.-i., Okayama, A., Watanabe, T., Arisawa, S., Stuver, S., Mueller, N., Hsieh, C.-c., Tsubouchi, H. The clonal expansion of HTLV-I infected cells: A comparison between seroconverters and long-term carriers. J Infect Dis 191:1140-1147, 2005. 79. Peters E.S., McClean M.D., Liu M., Eisen E.A., Mueller N., Kelsey K.T. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. . Cancer Epidemiol Biomarkers Prev 14:476-82, 2005. 80. Orjuela M., Titievsky L., Liu X. Ramirez-Ortiz M., Ponce-Castaneda M., Lecona E., Molina E., Beaverson K., Abramson D., Mueller N. Fruit and vegetable intake during pregnancy and risk for development of sporadic retinoblastoma. Cancer Epidemiol Biomarkers Prev 13
    • 14:1433-1400. 2005. 81. Stratigos, A.J., Malanos, D., Touloumi, G., Antoniou, A., Potouridou, E., Polydorou, D., Katsambas, A.D., Whitby, D., Mueller, N., Stratigos JD, Hatzakis, A. Association of clinical progression in classic Kaposi’s Sarcoma with reduction of peripheral B lymphocytes and partial increase in serum immune activation markers. Arch Dermatol 141:1421-1426, 2005. 82. Lajous M, Mueller N, Cruz-Valdez A, Aguilar LV, Franceschi S, Hernandez-Avila M, Lazcano-Ponce E. Determinants of prevalence, acquisition and persistence of human papillomavirus in healthy Mexican males. Cancer Epidemiol Biomarkers Prev 14:1710-1716, 2005. 83. Taniguchi Y., Nosaka K., Yasunaga J.-i., Maeda M., Mueller N., Okayama A., Matsuoka M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology. 2:64, 2005. 84. Birmann B.M., Mueller N.E., Okayama A., Hsieh C.C., Tsubouchi H., Harn D., Stuver S.O. Patterns of serum type 1 and type 2 immune markers in healthy carriers of HTLV-I. J Med Virology 78:770-779, 2006. 85. Suruki R., Mueller N., Hayashi K., Harn D., DeGruttola V., Raker C., Tsubouchi H., Stuver S. O. Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: A nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev 15:2521-2525, 2006. 86. Birmann B.M., Breen E.C., Stuver S., Cranston B., Martinez-Maza O., Falk K.L., Okayama A., Hanchard B., Mueller N., Hisada M. Population differences in immune marker profiles associated with human T0-lymphotropic virus type I infection in Japan and Jamaica. Int J Cancer 124:614-621, 2009. 87. Chang E.T., Birmann B.M., Kasperzyk J.L., Conti D.V., Kraft P., Ambinder R.F., Zheng T., Mueller N.E. Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 18:976-986, 2009. Book Chapters, Reviews, Commentaries, and other Invited Publications 1. Morrow, R.H., Gutensohn, N., Smith, P.G., Epstein-Barr Virus-malaria interaction models for Burkitt's lymphoma: implications for preventive trials. Cancer Research 36: 667-669, 1976. 2. Gutensohn, N., Cole, P., Epidemiology of Hodgkin's disease in the young. Int J Cancer 19: 595-604, 1977. 3. Gutensohn, N., Cole, P., The epidemiology of Hodgkin's disease. Seminars in Oncology 7: 92-102, 1980. 14
    • 4. Gutensohn, N., Essex, M., Francis, D.P., Hardy, W.D., Jr., Risk to humans from exposure to feline leukemia virus: epidemiologic considerations. In Viruses in Naturally Occurring Cancers. Cold Spring Harbor Conferences on Cell Proliferation, vol. 7: 699-706, 1980. 5. Francis, D.P., Essex, M., Cotter, S.M., Gutensohn, N., Jakowski, R., Hardy, W.D., Jr., Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus. Cancer Letters 12: 37-42, 1981. 6. Essex, M., Gutensohn, N., A comparison of the pathobiology and epidemiology of cancers associated with viruses in humans and animals. Prog Med Virol vol. 27, pp. 114-126, 1981. 7. Gutensohn, N., Social class and age at diagnosis of Hodgkin's disease: New epidemiologic evidence on the "two-disease" hypothesis. Cancer Treatment Rep 66: 689-695, 1982. 8. Gutensohn, N., The epidemiology of Hodgkin's disease: Clues to etiology. In Ford R., Fuller L., Hagemeister F., (eds.) New Perspectives in Human Lymphomas. Raven Press, New York, p. 3-9, 1984. 9. Gutensohn, N.M., Book review: Guidelines on Studies in Environmental Epidemiology. Environmental Health Criteria 27. IPCS International Programme on Chemical Safety. WHO, Geneva, 1983. Quarterly Review of Biology, vol. 60: 548-9, 1985. 10. Mueller, N.E., The epidemiology of Hodgkin's disease. In Selby P., McElwain T., (eds.) Hodgkin's Disease. Blackwell Scientific Publications, London, pp. 68-93, 1987. 11. Mueller, N., The epidemiology of the human immunodeficiency virus infection. Law, Medicine and Health Care 14: 250-8, 1987. 12. Mueller, N., Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease. Yale Journal of Biology and Medicine: 60: 321-7, 1987. 13. Mueller, N., Hatzakis, A., Opportunistic malignancies and the Acquired Immunodeficiency Syndrome. In: Unusual Occurrences as Clues of Cancer Etiology. J.F. Fraumeni, Jr. et al. (eds.), Japan Sci Soc Press, Tokyo, pp. 197-209, 1988. 14. Mueller, N., Tachibana, N., Stuver, S., Okayama, A., Shishime, E., Ishizaki, J., Murai,K., Shioiri, S., Tsuda, K., Epidemiologic perspectives of HTLV-I. In Blattner, W.A. (ed) Human Retrovirology: HTLV. pp. 281-293. Raven Press, New York, 1990. 15. Okayama, A., Ishizaki, J., Tachibana, N., Tsuda, K., Essex, M., Mueller, N., The particle agglutination (PA) assay and its use in detecting lower titer HTLV-I antibodies. In Blattner, W.A. (ed) Human Retrovirology: HTLV. pp. 401-407. Raven Press, New York, l990. 16. Evans, A.S., Mueller, N.E., Viruses and Cancer: Causal associations. Ann Epidem 1:71-92, 1990. 15
    • 17. Mueller, N., An epidemiologist's view of the new molecular biology findings in Hodgkin's disease. Proceedings of the Fourth International Conference on Malignant Lymphoma. Lugano, June 6-9,1990. Annals of Oncology 2: Supl 2:23-28, 1991. 18. Mueller, N., The epidemiology of HTLV-I infection. Cancer Causes and Control 2:37-52, 1991. 19. Mueller, N., The etiology of multiple myeloma: A role for viruses? In Obrams, I., Potter, M. (eds) Epidemiology and Biology of Myeloma pp. 103-108. Springer-Verlag, Berlin, 1991. 20. Trichopoulos, D., Mueller, N., Hatzakis, A., Epidemiology of AIDS. In: Olsen, J., Trichopoulos, D. (eds). Teaching of Epidemiology. pp. 254-269, Oxford University Press, Oxford, 1992. 21. Mueller, N., Mohar, A., Evans, A., Viruses other than HIV and non-Hodgkin's lymphoma. NCI Conference Proceedings: The Emerging Epidemic of Non-Hodgkin's Lymphoma: Current knowledge regarding etiological factors; Cancer Res (Suppl) 52:5479s-5481s, 1992. 22. Evans, A., Mueller, N., The past is prologue: The use of archival material in cancer research, (Ibid.) 52:5557s-5561s, 1992. 23. Mueller, N.E., Fraumeni, J.F., Jr., Research directions and general discussion: A summary. (Ibid.) 52:5571s, 1992. 24. International Agency for Research on Cancer (IARC) Ad Hoc Working Group. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 59: Hepatitis viruses. IARC, Lyon, France, 1994. 25. Mueller, N., Commentary: Another view of the epidemiology of Non-Hodgkin's lymphoma, Oncology, 9:83, 1994. 26. Broder, S., Miller, R.W., Hino, S., Blattner, W.A., Yoshida, M., Rosenblatt, J., Brady, J., Franchini, G., Tajima, K., Mueller, N., Takatsuki, K., Sonoda, S., Jacobson, S., Benveniste, R., Yanagihara, R., Gallo, R., Retroviruses and cancer - US-Japan clinico-epidemiological experiences held under the auspices of the US-Japan bilateral agreement. Leukemia 8(4):694-704, 1994. 27. Mueller, N., Overview: Viral agents and cancer. Proceedings of the President's Cancer Panel meeting "Avoidable Causes of Cancer", April 7-8, 1994. Environ Health Perspect 103 (Suppl 8):259-261, 1995. 28. Willett, W.C., Colditz, G.A., Mueller, N.E., Strategies for minimizing cancer risk. Sci Amer pp. 88-95, September, 1996. 29. Mueller, N., Evans, A.S., London, T., Viruses. In Schottenfeld, D., Fraumeni, J.F., Jr. (eds). Cancer Epidemiology and Prevention, Second Edition, pp. 502-531. Oxford University Press, New York, 1996. 16
    • 30. Mueller, N., Hodgkin's Disease. pp. 893-919 (Ibid.) 31. Scherr, P.A., Mueller, N., Non-Hodgkin's Lymphoma. pp. 920-945 (Ibid.) 32. International Agency for Research on Cancer (IARC) Ad Hoc Working Group. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 67; Human Immunodeficiency Viruses and Human T Lymphotropic Viruses. IARC, Lyon, France, 1996. 33. Mueller, N., Okayama, A., Stuver, S., Tachibana, N, Findings from the Miyazaki Cohort Study. JAIDS 13 (Suppl 1):S2-S7, 1996. 34. Mueller, N. E., Epstein-Barr virus and Hodgkin's disease: An epidemiological paradox. Epstein-Barr Virus Report 4:1-2, 1997. 35. International Agency for Research on Cancer (IARC) Ad Hoc Working Group. IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 70: Epstein-Barr virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. IARC, Lyon, France, 1997. 36. Evans, A.S., Mueller, N., Epstein-Barr virus and malignant lymphomas, In Evans, A.S., Kaslow, R. (eds.). Viral Infections of Humans: Epidemiology and Control Fourth Edition, pp. 895-933. Plenum Medical Book Company, New York, 1997. 37. Mueller, N., Blattner, W.A., Retroviruses - Human T-cell lymphotropic virus. (Ibid.) pp. 785-814. 38. Blattner, W.A., O'Brien, T., Mueller, N., Retroviruses - Human immunodeficiency virus. (Ibid.) pp. 713-783. 39. Mueller, N.E., Grufferman, S., Epidemiology. In Mauch, P., Armitage, J., Diehl, V., Hoppe, R., Weiss, L. (eds.) Hodgkin’s Disease pp. 61-78. Lippincott-Raven , New York, 1999. 40. Mueller, N. Overview of the epidemiology of malignancy in immune-deficiency. JAIDS 21 Suppl 1:S5-10, 1999. 41. Mueller, N., Infectious Agents. In Colditz, G.A., Hunter, D. (eds.) Cancer Prevention: the Causes and Prevention of Cancer. Kluwer Academic Publishers, Dordrecht, The Netherlands, 2000, pp. 63-74. 42. Mueller, N.E., Epidemiology: Hodgkin's Disease. In Hancock, B.W., MacLennan, K.A., Selby P. (eds.) Malignant Lymphomas, Edward Arnold Publishers, London, 2000, pp. 161-167. 43. Birmann, B., Chang, E., Mueller, N. Epidemiology of Lymphoma. In Grossbard, M.L. (ed.) Malignant Lymphoma, American Cancer Society Atlas of Clinical Oncology Series, BC Decker, Inc, Hamilton, Ontario 2002, pp.31-46. 17
    • 44. Mueller, N.E., Introduction to Session I: Cancers due infection: Unequal burdens. Cancer Epi Biomarkers Prev 12:237s,2003 (Supplement). 45. Mueller, N.E., Birmann, B.M., Parsonnet, J., Schiffman, M.H., Stuver, S.O. Infectious Agents. In Schottenfeld, D., Fraumeni, J.F., Jr. (eds.) Cancer Epidemiology and Prevention. Third Edition. Oxford University Press, 2006, pp. 507-548. 46. Mueller, N.E., Grufferman, S. Hodgkin Lymphoma. In Schottenfeld, D., Fraumeni, J.F., Jr. (eds.) Cancer Epidemiology and Prevention. Third Edition. Oxford University Press, 2006, pp.872-897. 47. Mueller, N.E,. Grufferman S., Chang, E.T. The Epidemiology of Hodgkin Lymphoma. In Hoppe, R., Mauch, P., Armitage, J., Diehl, V., Weiss, L. (eds.) Hodgkin’s Disease. Second Edition. Lippincott-Raven , New York, 2007, pp.7-24. 48. Trichopoulos, D., Cole, P., Cook, E.F., Feinleib, M., Hoover, R., Hsieh, C.C., Hunter, D., Monson, R., Mueller ,N., Rahu,M., Rimm, E,, Rothman, K., Stampfer, M., Weiss, N., Willett, W., Adami, H.O. Brian MacMahon (1923-2007): founder of modern epidemiology. Cancer Causes Control. 19:329-37. 2008. 49. Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Benbrahim- Tallaa, L., Guha. N., Freeman, C., Galichet, L., Cogliano, V. et al. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens –Part B: biological agents. Lancet Oncol. 10:321-2, 2009. 18
    • Letters to Editors 1. Gutensohn, N., Cole, P., Li, F.P.: Sibship size and Hodgkin's disease. N Engl J Med 292:025-1028, 1975. 2. Gutensohn, N., Cole, P.: Letter to the Editor. Int J Cancer 20: 632-35, 1977. 3. Gutensohn, N., Cole, P.: Immunity in Hodgkin's disease. Annals of Internal Medicine 91: 316-17, 1979. 4. Gutensohn, N. Cole, P.: Childhood social environment and Hodgkin's disease. N Engl J Med 304: 1171, 1981. 5. Welles, S.L., Mueller, N., Tachibana, N., Shishime, E., Okayama, A., Murai, K., Tsuda, K.: Decreased eosinophil numbers in HTLV-I carriers. Lancet 337:987, 1991. 6. Stuver, S.O., Mueller, N.E.: Re: Sexual transmission of human T-lymphotropic virus type I among female prostitutes and among patients with sexually transmitted disease in Fukuoka, Kyushu, Japan. Amer J Epidemiol 142:1247-1248, 1995. 7. Hisada, M., Mueller, N.E., Welles, S.L., Okayama, A. Re: Risk factors for non-Hodgkin's lymphoma in acquired immunodeficiency. Amer J Epidemiol 146:681-682, 1997. 8. Abtahi A., Mueller N., Okayama A., Stuver S.: Lack of evidence for a role of HTLV-I infection in the occurrence of subclinial HAM/TSP in the Miyazaki Cohort Study. J AIDS 24:86-7, 2000. 9. Stuver S.O., Boschi-Pinto C., Okayama A., Mueller N. Possible mechanism for positive interaction of HTLV-I on liver disease in an HCV-infected Japanese cohort. J Infect Dis 182:79-80, 2000. 10. Stuver S.O., Tanaka K., Ikematsu H., Okayama A., Tachibana N., Hirohata T., Kashiwagi S., Tsubouchi H., Mueller, N. Re: Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan. Int J Cancer 88:833-934, 2000. 11. Raker, C.A., Tabor, E., Okayama, A., Yu, M.-y. W., Kohara, M., Mueller, N.E., Tsubouchi, H., Stuver, S.O. HCV core antigen as an alternative to NAT to detect HCV viremia. Transfusion 44: 307-308, 2004. 12. Van Howe,R.S., Cold, C.J., Lajous,M., Lazcano-Ponce, E., Mueller, N. Re: Human papillomavirus link to circumcision is misleading. Cancer Epidemiol Biomarkers Prev 15:405, 2006. 19
    • Invited Lectures 1. "EBV-Malaria interaction models for Burkitt's lymphoma: Implications for preventive trials." Symposium on Immunological Control of Virus-associated Tumors in Man: Prospects and Problems. NCI, April 1975. 2. "Case-control study on childhood social environment and Hodgkin's disease." Society for Epidemiologic Research Student Workshop, University of Washington, June, 1977. 3. "Risk to humans from exposure to feline leukemia virus: Epidemiologic considerations." Symposium on Viruses in Naturally Occurring Cancers. Cold Spring Harbor, September 1979. 4. "Measuring Health Effects." Summer Institute on Hazardous Wastes: Issues, Problems, and Career Opportunities in the Eighties. Tufts University, July 1981. 5. "Social class and age at diagnosis." NCI Symposium on contemporary issues in Hodgkin's disease. San Francisco, September 1981. 6. "Assessing health effects of toxic waste exposure: Limitations and strengths of epidemiologic method." National Solid Wastes Management Association Annual Conference, October 1981. 7. "Hodgkin's disease and the EBV." National Bacteriologic Laboratory of Sweden, Department of Virology, May 1982. 8. "Viruses and Cancer." McGill University, Department of Epidemiology and Health, February 1983. 9. "Epidemiology and seroepidemiology of Hodgkin's disease." Yale University School of Medicine, Department of Epidemiology and Public Health Seminar Series, April 1983. 10. "Epidemiology of young adult Hodgkin's disease." New England Regional Primate Center, April 1983. 11. "Viral oncogenesis: Study design." NIH Research Workshop on the Epidemiology of AIDS, September 1983. 12. "The epidemiology of Hodgkin's disease: Clues to etiology." M.D. Anderson Conference on New Perspectives in Human Lymphoma, November 1983. 13. "A population-based case-control study of viral antibodies in patients with Hodgkin's disease and their siblings." American Epidemiology Society Annual Meeting, University of Pennsylvania, March 1984. 14. "Epidemiology of Hodgkin's disease." Yale University School of Medicine, Department of 20
    • Epidemiology and Public Health Seminar Series, March 1985. 15. "Epidemiology of Hodgkin's disease." Centers for Disease Control, Chronic Disease Division, April 1985. 16. "AIDS in the United States." Miyazaki Medical School, Second Department of Medicine, Miyazaki, Japan, December 1985. 17. "Current status of knowledge on AIDS and communicable disease in the workplace." Practicing Law Institute, New York City, August 1986. 18. "Epidemiologic studies assessing the role of EBV in Hodgkin's disease." American College of Epidemiology Annual Meeting, Yale University, September 1986. 19. "Epidemiology and natural history of AIDS", Society for Epidemiologic Research Annual Meeting, University of Massachusetts, July 1987. 20. "Epidemiology of HTLV-I." NCI Environmental Epidemiology Branch, August 1987. 21. "Opportunistic malignancies in AIDS." Princess Takematsu Cancer Research Foundation, Tokyo, Japan, November 1987. 22. "Epidemiology of HTLV-I." Kagoshima University School of Medicine, Kagoshima, Japan, November 1987. 23. "Transmission and natural history of HIV." Brown University Department of Community Health, AIDS Seminar Series, December 1987. 24. "Epidemiology of HTLV-I." Yale University School of Medicine, Department of Epidemiology and Public Health Seminar Series, December 1987. 25. "The epidemiology of HIV infection: Transmission and natural history", AAAS Annual meeting, Boston, February 1988. 26. "The Epidemiology of HTLV-I." Massachusetts State Laboratory Institute Seminar Series, April 1988. 27. "The Epidemiology of HTLV-I." University of Alabama School of Public Health, Department of Epidemiology, May 1988. 28. "The natural history of HTLV-I: A prospective cohort study." American Epidemiology Society Annual Meeting, Tampa, March 1989. 29. "Epidemiologic perspectives on HTLV-I." Second International Meeting on HTLV, Trinidad, March 1989. 30. "The epidemiology and prevention of HTLV-I infection." First National Conference on AIDS and STD, Athens, Greece, January 1990. 21
    • 31. "Suppression of delayed-type hypersensitivity to PPD and PHA among elderly HTLV-I carriers in Miyazaki Prefecture, Japan." Third Annual Retrovirology Conference, Maui, February 1990. 32. "Viral and Infectious Agents." NCI Workshop on Multiple Myeloma, Bethesda, MD, March 1990. 33. "An epidemiologic view of the new cytogenic findings in Hodgkin's disease." Fourth International Conference on Malignant Lymphoma, Lugano, Switzerland, June 1990. 34. "The epidemiology of HTLV-I." Seminar Chair, International Congress for Infectious Diseases, Montreal, Canada, July 1990. 35. "The AIDS Epidemic in Mexico." University of Nebraska Medical Center, Department of Preventive and Societal Medicine, October 1990. 36. "The EBV and Hodgkin's disease." Grand Rounds, University of Nebraska Medical Center, October 1990. 37. "Increased overall mortality rates among HTLV-I carriers: Preliminary result from the Miyazaki Cohort Study." Fourth Annual International Retrovirus Conference, Jamaica, February 1991. 38. "Epidemiology of HTLV-I and ATL." Causes, Consequences and Cures of Lymphoproliferative Diseases: A Symposium to Honor George and Eva Klein, University of Nebraska Medical Center, May 1991. 39. "Clinical/epidemiologic studies of HIV infectiousness and transmission." Panel Chair, NIAID and CDC Workshop on Biology of Heterosexual Transmission of HIV, May 1991. 40. "World-wide incidence of human cancers linked to viral infections." Viral-chemical Interactions in Human Cancers, IARC, Lyon, France, June 1991. 41. "Viruses other than HIV." Workshop on the time trends in non-Hodgkin's lymphoma: Current knowledge and recommendations for research, NCI, Bethesda, MD, October 1991. 42. "The epidemiology of HTLV-I." Grand Rounds, Spaulding Rehabilitation Hospital, January 1992. 43. "The epidemiology of HTLV-I: Challenges for future research." Fifth International Conference on Human Retrovirology; HTLV, Kumamoto, Japan, May 1992. 44. "AIDS in women: Research challenges." Society for Epidemiologic Research Annual Meeting, Minneapolis, June 1992. 22
    • 45. "HTLV-I: Epidemiology and Clinical Spectrum." American College of Epidemiology Pre-Conference Workshop on Infection, Immunodeficiency and Cancer, Bethesda, September 1992. 46. "The use of viral markers in epidemiologic studies: A population-based cohort study of HTLV-I infection." American Association for Cancer Research Special Conference on Molecular and Biochemical Methods in Cancer Epidemiology and Prevention - The Path Between the Laboratory and the Population, Naples, Florida, September 1992. 47. "HTLV-I: Current knowledge and epidemiologic strategies." Retroviruses and Cancer: US-Japan clinico-epidemiological experiences, NIH, January 1993. 48. "The natural history of HTLV-I infection: Results from a prospective epidemiologic study." Annual Meeting of the Laboratory of Tumor Cell Biology, Bethesda, August 1993. 49. "Epidemiology of HTLV-I infection." Roxbury Society for Medical Improvement, Brookline, Massachusetts, October 1993. 50. "The Epstein-Barr Virus and Hodgkin's disease." Department of Epidemiology Seminar, Johns Hopkins University School of Hygiene and Public Health, December 1993. 51. "Overview-viral agents." Avoidable Causes of Cancer, President's Cancer Panel, Bethesda, MD, April 1994. 52. "The relationship of HTLV-I status, smoking, and sex as predictors of abnormal lymphocytes." And Rapporteur: Epidemiology Track. Sixth International Conference on Human Retrovirology: HTLV, Absecon, N.J., May 1994. 53. "Epidemiology of HTLV-I." Beth Israel Hospital/Brigham & Women's Hospital, Hematology/Oncology Grand Rounds, September 1994. 54. "Evaluation of morbidity among HTLV-I carriers in Miyazaki, Japan." 1994 Annual Meeting Sponsored by the Laboratory of Tumor Cell Biology, Rockville, MD, October 1994. 55. "Epidemiology of non-Hodgkin's lymphoma." Symposium on the Malignant Lymphomas, Harvard Collaborative Oncology Group, April 1995. 56. "The epidemiology of EBV-associated malignancy." Second Department of Medicine, Miyazaki Medical School, Japan, June 1995. 57. Discussant: "EBV in Hodgkin's disease." Third International Symposium on Hodgkin's Lymphoma, Cologne, Germany, September 1995. 58. "Increased mortality from virus-associated malignancies other than ATL among HTLV-I carriers in the Miyazaki Cohort Study." Seventh International Conference on Human Retrovirology: HTLV. Paris, France, October 1995. 23
    • 59. "The EBV and Cancer: A challenge to molecular epidemiology". Alfred S. Evans Lecture. University of Michigan Graduate Program in Epidemiology, Ann Arbor, July 1996. 60. Discussant: HTLV-I and II. Annual Meeting of the Institute of Human Virology, Baltimore, September 1996. 61. "Epidemiologic Strategies." Symposium on the Basic Sciences of Head and Neck Cancer, Harvard Collaborative Oncology Group, December 1996. 62. "Creating a rapid case identification unit: the Massachusetts experience." Annual Conference, North American Association of Central Cancer Registries, April 1997. 63. Case Study - A Breast Cancer “Epidemic”. Cancer Prevention and Control Academic Course, NCI, August 1997; 1998. 64. “Overview: Epidemiology of malignancy in immune-suppression.” The Second National AIDS Malignancy Conference, Bethesda, April 1998. 65. “Low anti-EBNA-1 and high anti-EBNA-2 levels in Hodgkin’s disease cases and controls with history of infectious mononucleosis.” International Conference on Tumor Associated Herpesviruses, Stockholm, June 1998. 66. “Viruses and cancer.” Nordic Summer Course in Infectious Disease Epidemiology. Stockholm, June 1998. 67. Discussant: Infectious Agents and Cancer. ACS Schilling Research Conference, “The Environment and Cancer”, Santa Cruz, March 1999. 68. “The association of reported HAM-related symptoms among HTLV-I carriers in the Miyazaki Cohort Study.” Ninth International Conference on Human Retrovirology: HTLV and related Viruses. Kagoshima, April 1999. 69. Symposium Convener: “Infectious Agents and Cancer.” AACR Annual Meeting, Philadelphia, April 1999. 70. “The EBV and Hodgkin’s disease: An epidemiological perspective.” Stohlman Scholar Symposium, Leukemia Society of America, November 1999. 71. “The epidemiology of Hodgkin’s disease.” Radiation Oncology Review Lecture Series, Harvard Medical School, February 2000. 72. “Viruses and Cancer.” Lahey Clinic Grand Rounds, February, 2000. 73. “EBV-associated malignancies.” NCI Workshop on Viruses in Human Cancer, Washington, March 2001. 24
    • 74. “The blind epidemiologists and the elephant: The natural history of HTLV-I infection.” Tenth International Conference on Human Retrovirology: HTLV and Related Viruses. Dublin, June 2001. 75. “Preliminary results from a program project study on the etiology of Hodgkin’s disease.” Brown University Medical School, October, 2001. 76. “The potential role of infectious agents in the etiology of childhood cancer.” NCI Workshop on Gene-Environment Interactions in the Etiology of Childhood Cancer. Bethesda, March 2002. 77. “New findings in the epidemiology of adult Hodgkin’s lymphoma.” EBV and Hodgkin’s Research Seminar. Johns Hopkins Medical School, September, 2002. 78. “The viral etiology of Hodgkin’s lymphoma: Epidemiologic evidence for a role of EBV in both EBV(+) and EBV(-) cases.” International Symposium of Epstein-Barr virus and Associated Diseases. Regensburg, September 2004. 79. “Infections and cancer: What do we know? Where do we go?” Distinguished Lecture Series, Genetic Epidemiology Research Institute. University of California, Irwin, December 2004. 80. “Infections and cancer: What do we know? Where do we go?” Visiting Scholar Lecture, NCI Division of Cancer Epidemiology & Genetics. February 2005. 81. “The utility of rapid case ascertainment for a population-based case-control study on Hodgkin’s lymphoma” North American Association of Central Cancer Registries Annual Meeting, Boston, June, 2005. 82. “The epidemiology of HTLV-I infection: Where do we go from here?” 12th International Conference on Human Retrovirology: HTLV and Related Viruses. Jamaica, June, 2005. 83. “My 30-year love affair with Hodgkin’s lymphoma: Lessons learned” Keynote Speech, Second NCI Epidemiology Leadership Workshop: Understudied Rare Cancers. Boston, September, 2005. 84. “HTLV-I: the first human cancer-causing retrovirus: What we know and why we don’t know more” 144th Cutter Lecture, HSPH, May, 2006. 25